Erythema induratum: Case series illustrating the utility of the interferon-γ release assay in determining the association with tuberculosis

Vimal Prajapati, McKay Steed, Parbeer Grewal, Muhammad N. Mahmood, Geetika Verma, Alain Brassard

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: The interferon-γ release assay (IGRA) is a novel method for detecting previous sensitization to tuberculosis (TB). Despite having several advantages over the tuberculin skin test (TST), including higher specificity and no influence from past bacille Calmette-Guérin (BCG) exposure, there are a limited number of reports describing its application in patients with erythema induratum (EI)/nodular vasculitis (NV), which is usually but not always related to TB. Objectives: The aim of our case series was to evaluate the usefulness of the IGRA for determining a TB association in patients with EI/NV. Methods: Retrospective chart reviews were conducted on four patients diagnosed with EI/NV at our institution in whom an IGRA had been performed. Results: All four subjects had positive TST results. The IGRA was also positive and therefore supported a link with TB in two cases. One patient responded completely to anti-TB therapy, whereas the second was lost to follow-up. Both cases unrelated to TB, by virtue of negative IGRAs, demonstrated complete response to immunosuppressive therapy (methotrexate), with one individual having failed anti-TB therapy first. Conclusion: Our case series highlights the utility of the IGRA for establishing a TB association in patients with EI/NV. Although limited by a small sample size, we propose adjunctive use of this test at the time of EI/NV diagnosis, especially in the setting of previous BCG exposure, so that management can be tailored according to whether an underlying relationship with TB exists.

Original languageEnglish (US)
JournalJournal of Cutaneous Medicine and Surgery
Volume17
Issue numberSUPPL.1
DOIs
StatePublished - Jul 1 2013
Externally publishedYes

Fingerprint

Erythema Induratum
Interferons
Tuberculosis
Vasculitis
Tuberculin Test
Skin Tests
Lost to Follow-Up
Immunosuppressive Agents
Methotrexate
Sample Size
Therapeutics

ASJC Scopus subject areas

  • Dermatology
  • Surgery

Cite this

Erythema induratum : Case series illustrating the utility of the interferon-γ release assay in determining the association with tuberculosis. / Prajapati, Vimal; Steed, McKay; Grewal, Parbeer; Mahmood, Muhammad N.; Verma, Geetika; Brassard, Alain.

In: Journal of Cutaneous Medicine and Surgery, Vol. 17, No. SUPPL.1, 01.07.2013.

Research output: Contribution to journalArticle

@article{6192a4c077634ba2b65fcaa5a3f390db,
title = "Erythema induratum: Case series illustrating the utility of the interferon-γ release assay in determining the association with tuberculosis",
abstract = "Background: The interferon-γ release assay (IGRA) is a novel method for detecting previous sensitization to tuberculosis (TB). Despite having several advantages over the tuberculin skin test (TST), including higher specificity and no influence from past bacille Calmette-Gu{\'e}rin (BCG) exposure, there are a limited number of reports describing its application in patients with erythema induratum (EI)/nodular vasculitis (NV), which is usually but not always related to TB. Objectives: The aim of our case series was to evaluate the usefulness of the IGRA for determining a TB association in patients with EI/NV. Methods: Retrospective chart reviews were conducted on four patients diagnosed with EI/NV at our institution in whom an IGRA had been performed. Results: All four subjects had positive TST results. The IGRA was also positive and therefore supported a link with TB in two cases. One patient responded completely to anti-TB therapy, whereas the second was lost to follow-up. Both cases unrelated to TB, by virtue of negative IGRAs, demonstrated complete response to immunosuppressive therapy (methotrexate), with one individual having failed anti-TB therapy first. Conclusion: Our case series highlights the utility of the IGRA for establishing a TB association in patients with EI/NV. Although limited by a small sample size, we propose adjunctive use of this test at the time of EI/NV diagnosis, especially in the setting of previous BCG exposure, so that management can be tailored according to whether an underlying relationship with TB exists.",
author = "Vimal Prajapati and McKay Steed and Parbeer Grewal and Mahmood, {Muhammad N.} and Geetika Verma and Alain Brassard",
year = "2013",
month = "7",
day = "1",
doi = "10.2310/7750.2013.WOUND4",
language = "English (US)",
volume = "17",
journal = "Journal of Cutaneous Medicine and Surgery",
issn = "1203-4754",
publisher = "Decker Publishing",
number = "SUPPL.1",

}

TY - JOUR

T1 - Erythema induratum

T2 - Case series illustrating the utility of the interferon-γ release assay in determining the association with tuberculosis

AU - Prajapati, Vimal

AU - Steed, McKay

AU - Grewal, Parbeer

AU - Mahmood, Muhammad N.

AU - Verma, Geetika

AU - Brassard, Alain

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Background: The interferon-γ release assay (IGRA) is a novel method for detecting previous sensitization to tuberculosis (TB). Despite having several advantages over the tuberculin skin test (TST), including higher specificity and no influence from past bacille Calmette-Guérin (BCG) exposure, there are a limited number of reports describing its application in patients with erythema induratum (EI)/nodular vasculitis (NV), which is usually but not always related to TB. Objectives: The aim of our case series was to evaluate the usefulness of the IGRA for determining a TB association in patients with EI/NV. Methods: Retrospective chart reviews were conducted on four patients diagnosed with EI/NV at our institution in whom an IGRA had been performed. Results: All four subjects had positive TST results. The IGRA was also positive and therefore supported a link with TB in two cases. One patient responded completely to anti-TB therapy, whereas the second was lost to follow-up. Both cases unrelated to TB, by virtue of negative IGRAs, demonstrated complete response to immunosuppressive therapy (methotrexate), with one individual having failed anti-TB therapy first. Conclusion: Our case series highlights the utility of the IGRA for establishing a TB association in patients with EI/NV. Although limited by a small sample size, we propose adjunctive use of this test at the time of EI/NV diagnosis, especially in the setting of previous BCG exposure, so that management can be tailored according to whether an underlying relationship with TB exists.

AB - Background: The interferon-γ release assay (IGRA) is a novel method for detecting previous sensitization to tuberculosis (TB). Despite having several advantages over the tuberculin skin test (TST), including higher specificity and no influence from past bacille Calmette-Guérin (BCG) exposure, there are a limited number of reports describing its application in patients with erythema induratum (EI)/nodular vasculitis (NV), which is usually but not always related to TB. Objectives: The aim of our case series was to evaluate the usefulness of the IGRA for determining a TB association in patients with EI/NV. Methods: Retrospective chart reviews were conducted on four patients diagnosed with EI/NV at our institution in whom an IGRA had been performed. Results: All four subjects had positive TST results. The IGRA was also positive and therefore supported a link with TB in two cases. One patient responded completely to anti-TB therapy, whereas the second was lost to follow-up. Both cases unrelated to TB, by virtue of negative IGRAs, demonstrated complete response to immunosuppressive therapy (methotrexate), with one individual having failed anti-TB therapy first. Conclusion: Our case series highlights the utility of the IGRA for establishing a TB association in patients with EI/NV. Although limited by a small sample size, we propose adjunctive use of this test at the time of EI/NV diagnosis, especially in the setting of previous BCG exposure, so that management can be tailored according to whether an underlying relationship with TB exists.

UR - http://www.scopus.com/inward/record.url?scp=84885750306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885750306&partnerID=8YFLogxK

U2 - 10.2310/7750.2013.WOUND4

DO - 10.2310/7750.2013.WOUND4

M3 - Article

C2 - 24144256

AN - SCOPUS:84885750306

VL - 17

JO - Journal of Cutaneous Medicine and Surgery

JF - Journal of Cutaneous Medicine and Surgery

SN - 1203-4754

IS - SUPPL.1

ER -